Review



atcc accession number  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ATCC atcc accession number
    Atcc Accession Number, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 57 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atcc+accession+207180/E%2Ecoli+w%2F+human+Tango+268+insert+EpthEa11d1/us08137923-73-47-47
    Average 90 stars, based on 57 article reviews
    atcc accession number - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Glycoprotein VI and uses thereof
    Article Snippet: The invention features nucleic acid molecules which are at least 35%, 40%, 45%, 50%, 55%, 65%, 75%, 85%, 95%, or 98% identical to the nucleotide sequence of SEQ ID NO:15 the nucleotide sequence of the cDNA insert of an EpTm268 clone deposited with ATCC as patent deposit Number PTA-225, or a complement thereof. .. The invention features nucleic acid molecules which are at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% identical to the nucleotide sequence of SEQ ID NO: 1, 2, 14, 15, 33, 35, 37, 39, 41, 43, 45 or 47, a complement thereof, or the non-coding strand of EpthEa11d1 or EpTm268 cDNA of ATCC Accession 207180 or patent deposit Number PTA-225, wherein said nucleic acid molecules encode polypeptides or proteins that exhibit at least one structural and/or functional feature of a polypeptide of the invention. .. The invention features nucleic acid molecules which include a fragment of at least 550, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900 or 2000 contiguous nucleotides of the nucleotide sequence of SEQ ID NO:1, the nucleotide sequence of an EpthEa11d1 cDNA of ATCC Accession Number 207180, or a complement thereof.

    Article Title: Glycoprotein VI and uses thereof
    Article Snippet: .. The invention features isolated nucleic acid molecules having a nucleotide sequence that is at least about 20, 50, 100, 150, 200, 250, 300, 400, 450, 500, 550, 600, 650, 700 or more contiguous nucleotides identical to the nucleic acid sequence of SEQ ID NOS: 1, 2, 14 15, 33, 35, 37, 39, 41, 43, 45 or 47, or a complement thereof, or the non-coding strand of EpthEa11d1 or EpTm268 cDNA of ATCC Accession 207180 or patent deposit Number PTA-225, wherein said nucleic acid molecules encode polypeptides or proteins that exhibit at least one structural and/or functional feature of a polypeptide of the invention. .. The invention also features nucleic acid molecules which include a nucleotide sequence encoding a protein having an amino acid sequence that is at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 75%, 85%, 95%, or 98% identical to the amino acid sequence of SEQ ID NO:3, the amino acid sequence encoded by an EpthEa11d1 cDNA of ATCC Accession Number 207180, or a complement thereof.

    Functional Assay:

    Article Title: Glycoprotein VI and uses thereof
    Article Snippet: The invention features nucleic acid molecules which are at least 35%, 40%, 45%, 50%, 55%, 65%, 75%, 85%, 95%, or 98% identical to the nucleotide sequence of SEQ ID NO:15 the nucleotide sequence of the cDNA insert of an EpTm268 clone deposited with ATCC as patent deposit Number PTA-225, or a complement thereof. .. The invention features nucleic acid molecules which are at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or 98% identical to the nucleotide sequence of SEQ ID NO: 1, 2, 14, 15, 33, 35, 37, 39, 41, 43, 45 or 47, a complement thereof, or the non-coding strand of EpthEa11d1 or EpTm268 cDNA of ATCC Accession 207180 or patent deposit Number PTA-225, wherein said nucleic acid molecules encode polypeptides or proteins that exhibit at least one structural and/or functional feature of a polypeptide of the invention. .. The invention features nucleic acid molecules which include a fragment of at least 550, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900 or 2000 contiguous nucleotides of the nucleotide sequence of SEQ ID NO:1, the nucleotide sequence of an EpthEa11d1 cDNA of ATCC Accession Number 207180, or a complement thereof.

    Article Title: Glycoprotein VI and uses thereof
    Article Snippet: .. The invention features isolated nucleic acid molecules having a nucleotide sequence that is at least about 20, 50, 100, 150, 200, 250, 300, 400, 450, 500, 550, 600, 650, 700 or more contiguous nucleotides identical to the nucleic acid sequence of SEQ ID NOS: 1, 2, 14 15, 33, 35, 37, 39, 41, 43, 45 or 47, or a complement thereof, or the non-coding strand of EpthEa11d1 or EpTm268 cDNA of ATCC Accession 207180 or patent deposit Number PTA-225, wherein said nucleic acid molecules encode polypeptides or proteins that exhibit at least one structural and/or functional feature of a polypeptide of the invention. .. The invention also features nucleic acid molecules which include a nucleotide sequence encoding a protein having an amino acid sequence that is at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 75%, 85%, 95%, or 98% identical to the amino acid sequence of SEQ ID NO:3, the amino acid sequence encoded by an EpthEa11d1 cDNA of ATCC Accession Number 207180, or a complement thereof.

    Isolation:

    Article Title: Glycoprotein VI and uses thereof
    Article Snippet: .. The invention features isolated nucleic acid molecules having a nucleotide sequence that is at least about 20, 50, 100, 150, 200, 250, 300, 400, 450, 500, 550, 600, 650, 700 or more contiguous nucleotides identical to the nucleic acid sequence of SEQ ID NOS: 1, 2, 14 15, 33, 35, 37, 39, 41, 43, 45 or 47, or a complement thereof, or the non-coding strand of EpthEa11d1 or EpTm268 cDNA of ATCC Accession 207180 or patent deposit Number PTA-225, wherein said nucleic acid molecules encode polypeptides or proteins that exhibit at least one structural and/or functional feature of a polypeptide of the invention. .. The invention also features nucleic acid molecules which include a nucleotide sequence encoding a protein having an amino acid sequence that is at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 75%, 85%, 95%, or 98% identical to the amino acid sequence of SEQ ID NO:3, the amino acid sequence encoded by an EpthEa11d1 cDNA of ATCC Accession Number 207180, or a complement thereof.



    Similar Products

    atcc accession number  (ATCC)
    90
    ATCC atcc accession number
    Atcc Accession Number, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atcc+accession+207180/E%2Ecoli+w%2F+human+Tango+268+insert+EpthEa11d1/us08137923-73-47-47
    Average 90 stars, based on 1 article reviews
    atcc accession number - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    accession number  (ATCC)
    90
    ATCC accession number
    Accession Number, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/atcc+accession+207180/E%2Ecoli+w%2F+human+Tango+268+insert+EpthEa11d1/us08137923-106-58-56
    Average 90 stars, based on 1 article reviews
    accession number - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results